Genitourinary Radiology: Page 20

Cystatin C better than Cr for detecting contrast-induced kidney injury

By Reuters Health

NEW YORK (Reuters Health), May 20 - Measurement of serum cystatin C helps diagnose early acute contrast-induced kidney injury, and it also helps predict its course, Italian researchers report. They studied 410 patients with chronic kidney disease who underwent coronary and/or peripheral angiography and/or angioplasty.

May 19, 2010

Ultrasound useful in infants with first urinary tract infection

By Reuters Health

NEW YORK (Reuters Health), Apr 7 - Ultrasound can be useful in the workup of infants with a first urinary tract infection, researchers from Sweden report in the May issue of The Journal of Urology. To learn more about the role of ultrasound, the investigators obtained scans in 290 infants with a first urinary tract infection.

April 6, 2010

Varian contributes to novel research

By AuntMinnieEurope.com staff writers

With the help of technology from radiation therapy firm Varian Medical Systems, researchers in the U.S. and Denmark have devised a method for real-time tracking of prostate motion.

March 3, 2010

1.5-tesla MRI pinpoints, stages testicular masses

By Wayne Forrest

MRI is an efficient diagnostic tool to evaluate testicular masses and accurately differentiate between benign and malignant intratesticular tumors, according to a study published in the March issue of the American Journal of Roentgenology.

March 3, 2010

Men may benefit from testosterone replacement

By AuntMinnieEurope.com staff writers

Male cancer survivors who develop testosterone deficiency after receiving radiation therapy and/or chemotherapy may benefit from testosterone replacement therapy, according to a U.K. study.

February 25, 2010

Biochemical failure of high-intensity ultrasound for prostate CA redefined

By Reuters Health

NEW YORK (Reuters Health), Oct 16 - An increase in prostate-specific antigen level of 1.2 ng/mL over the nadir should be considered a biochemical failure after high-intensity focused ultrasound for prostate cancer, according to authors of a paper in the October issue of BJU International.

October 15, 2009

Algeta, Bayer join forces

By AuntMinnieEurope.com staff writers

Therapeutic radiopharmaceutical developer Algeta has inked an $800 million agreement with Bayer for the development and commercialization of its Alpharadin alpha-emitting pharmaceutical for treating bone metastases.

September 7, 2009

PET/CT may help detect recurring prostate cancer earlier

By AuntMinnieEurope.com staff writers

PET/CT scans with the imaging agent choline could detect recurring prostate cancer sooner than conventional imaging technologies in some patients who have had their prostates surgically removed.

September 1, 2009

Resonant to unveil new Clarity version

By AuntMinnieEurope.com staff writers

Ultrasound image-guided radiation therapy (IGRT) developer Resonant Medical will showcase the next generation of its Clarity IGRT system at next week's European Society for Therapeutic Radiology and Oncology annual meeting.

September 1, 2009

Hormone therapy ups survival of radiation-treated men with prostate cancer

By Reuters Health

NEW YORK (Reuters Health), Jul 28 - Adding hormone therapy to radiotherapy for locally advanced prostate cancer reduces disease recurrence and prolongs survival, according to a report in the August 1 issue of Cancer.

July 27, 2009

New form of radiotherapy for prostate cancer works in mice

By Reuters Health

NEW YORK (Reuters Health), Jun 18 - The alpha particle-emitting radiopeptide 213 Bi-DOTA-PESIN is effective for treating prostate cancer in mice, according to research presented at the SNM's annual meeting in Toronto this week.

June 17, 2009

SNM study: Radiopeptides for prostate cancer look promising

By AuntMinnieEurope.com staff writers

A potential new weapon in the arsenal for treating prostate cancer is being discussed at this week's SNM annual meeting in Toronto.

June 14, 2009

Previous Page

Page 20 of 22

Next Page